Clinical trials aimed at reducing obesity with leptin administration have proven to be disappointing overall, however, likely owing to the fact that obese individuals demonstrate elevated circulating leptin levels (hyperleptinemia) due to increased adiposity and the presence of leptin resistance in these individuals [3]. The gene discussed is LEP; the disease is Obesity.